Anthropic is launching its own drug discovery programs for rare diseases using Claude superintelligence
Favicon 
www.sgtreport.com

Anthropic is launching its own drug discovery programs for rare diseases using Claude superintelligence

by Lance D Johnson, Natural News: The news landed like a thunderclap in a San Francisco conference room on June 30, 2026. Anthropic, the artificial intelligence company behind the cutting-edge Claude model, announced it will launch its own preclinical drug-discovery programs targeting neglected diseases, including rare conditions, while simultaneously unveiling Claude Science, an AI workbench built […]